RTI Biologics has signed an exclusive, 10-year distribution agreement with Zimmer Dental whereby Zimmer will market and distribute RTI implants for the dental market worldwide.
Under the terms of the new agreement, which takes effect September 30, 2010, RTI will supply sterilized allograft and xenograft implants for an agreed upon transfer fee (as opposed to the marketing fee structure of the companies' previous agreement). Zimmer will be responsible for worldwide marketing and distribution of the implants.
The new agreement includes an initial payment, as well as annual payments for the length of the contract, to secure exclusive distribution rights in the dental market. Additionally, Zimmer has committed to annual order minimums to preserve exclusivity.
Copyright © 2010 DrBicuspid.com